Sucampo, Takeda start lubiprostone Phase IIIs

Sucampo (Bethesda, Md.) received a $20 million milestone payment from Takeda (Osaka, Japan) that was triggered by the start of two Phase III trials of lubiprostone to treat constipation-predominant ir...